During the past decade, Hopital Dupuytren; Pneumologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Dupuytren; Pneumologie" #1 collaborator was "Exelixis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Dupuytren; Pneumologie" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Hopital Dupuytren; Pneumologie" in a lesser frequency.

Most popular intervention types in "Hopital Dupuytren; Pneumologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Cabozantinib" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Dupuytren; Pneumologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Dupuytren; Pneumologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Dupuytren; Pneumologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Dupuytren; Pneumologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".